Statistics
Total Visits
| Views | |
|---|---|
| Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine | 258 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine | 3 | 5 | 1 | 1 | 3 | 4 | 6 | 3 | 6 | 7 | 7 |
File Visits
| Views | |
|---|---|
| CidSilva_Treatment.pdf | 572 |
Top country views
| Views | |
|---|---|
| United States | 161 |
| Sweden | 14 |
| China | 13 |
| Germany | 11 |
| Ireland | 8 |
| Spain | 7 |
| Belgium | 5 |
| Ukraine | 5 |
| Finland | 4 |
| Netherlands | 3 |
Top cities views
| Views | |
|---|---|
| Ashburn | 55 |
| Fairfield | 19 |
| Cambridge | 8 |
| Dublin | 8 |
| Ann Arbor | 7 |
| Falls Church | 7 |
| Fremont | 7 |
| Louisville | 7 |
| Mountain View | 7 |
| Stockholm | 7 |
